ArticleJournal of cellular and molecular medicine2019

LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.

Chengjun Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.